Overcoming Obstacles of the Canadian Drug Regulatory Landscape

Website https://www.compliance4all.com/control/w_product/~product_id=502454LIVE?channel=ourglocal_May_2019_S | Edit Freely

Category Biotech Executives, Decision Makers, Study Sponsors

Deadline: May 25, 2019 | Date: May 28, 2019

Venue/Country: Online, U.S.A

Updated: 2019-03-20 15:14:06 (GMT+9)

Call For Papers - CFP

Through this presentation, you will develop a comprehensive understanding of the Drug Approval Process and in parallel examine major misconceptions and misunderstandings.

Why should you Attend:

We will share insights and practical examples that facilitate a positive, proactive and transparent interaction with Health Canada, and provide strategies for avoiding obstacles and managing them efficiently should they occur.

Areas Covered in the Session:

Key strategic considerations at various stages of the Drug Development Process

The broader principals of the drug registration approach in Canada

Tips that will improve your efficiency and increase opportunities for successful market access

Who Will Benefit:

Pharma

Biotech Executives

Decision Makers

Study Sponsors

Speaker Profile:

Susanne Picard Founder and President of SPharm, is a sought-after expert on all aspects of the regulatory landscape. SPharm is a leading regulatory affairs consultancy headquartered in Canada that services clients around the globe.

Event Fee: One Dial-in One Attendee Price: US $150.00

Contact Detail:

Compliance4All DBA NetZealous,

Phone: +1-800-447-9407

Email: compliance4all14gmail.com